SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Reprint of "The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking"

    González A (1), López B (2), Ravassa S (2), San José G (2), Díez J (3)

    (1) Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
    (2) Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
    (3) Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain; Departments of Cardiology and Cardiac Surgery and of Nephrology, Clínica Universidad de Navarra, Pamplona, Spain.

    Biochimica and Biophysical Acta. Molecular Cell Research 05 AUGUST 2019

  • Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats

    Ezquerro S (1,2), Becerril S (1,2), Tuero C (3), Méndez-Giménez L (1,2), Mocha F (1), Moncada R (2,4), Valentí V (2,3), Cienfuegos JA (2,3), Catalán V (1,2), Gómez-Ambrosi J (1,2), Piper Hanley K (5), Frühbeck G (1,2,6), Rodríguez A (7,8).

    (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, IdiSNA, Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
    (3) Department of Surgery, Clínica Universidad de Navarra, IdiSNA, Pamplona, Spain.
    (4) Department of Anesthesia, Clínica Universidad de Navarra, IdiSNA, Pamplona, Spain.
    (5) Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
    (6) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, IdiSNA, Pamplona, Spain.
    (7) Metabolic Research Laboratory, Clínica Universidad de Navarra, IdiSNA, Pamplona, Spain.
    (8) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.

    International Journal of Obesity 19 JULY 2019

  • Risk of Ovarian Malignancy Algorithm versus Risk Malignancy Index-I for Preoperative Assessment of Adnexal Masses

    Chacón E (1), Dasí J (2), Caballero C (3), Alcázar JL (4).

    (1) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Obstetrics and Gynecology, University and Polytechnic hospital "La Fe", Valencia, Spain.
    (3) Department of Obstetrics and Gynecology, Women's and Children Hospital, Badajoz, Spain.
    (4) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.

    Gynecologic and Obstetric Investigation 16 JULY 2019

  • Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Steward T (1,2), Mestre-Bach G (1,2), Granero R (2,3), Sánchez I (1,2), Riesco N (1,2), Vintró-Alcaraz C (1,2), Sauchelli S (1), Jiménez-Murcia S (1,2,4), Agüera Z (1,2), Fernández-García JC (2,5), Garrido-Sánchez L (2,5), Tinahones FJ (2,5), Casanueva FF (2,6), Baños RM (2,7), Botella C (2), Crujeiras AB (2,6), Torre R (2,8,9), Fernández-Real JM (2,10), Frühbeck G (2,11), Ortega FJ (2,10), Rodríguez A (2,11), Menchón JM (1,4,12), Fernández-Aranda F (13,14,15).

    (1) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (2) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (3) Departament de Psicobiologia i Metodologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
    (4) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.
    (5) Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Hospital Clínico Virgen de la Victoria, Málaga, Spain.
    (6) Molecular and Celular Endocrinology, Instituto de Investigacion Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.
    (7) Department of Psychological, Personality, Evaluation and Treatment of the University of Valencia, Valencia, Spain.
    (8) Integrated Pharmacology and Systems Neurosciences Research Group, Neuroscience Research Program Organization IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
    (9) Department of Health and Experimental Sciences, Universitat Pompeu Fabra Barcelona, Barcelona, Spain.
    (10) Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació, Biomèdica de Girona (IdIBGi), Hospital Dr Josep Trueta, Girona, Spain.
    (11) Metabolic Research Laboratory, Clínica Universidad de Navarra, University of Navarra-IdiSNA, Pamplona, Spain.
    (12) CIBER Salud Mental, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (13) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (14) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (15) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.

    Scientific Reports 27 MAY 2019

  • Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

    Vera R (1), Otero MJ (2), Ayala de la Peña F (3), González-Pérez C (4), Peñuelas Á (5), Sepúlveda JM (6), Quer N (7), Doménech-Climent N (8,9), Virizuela JA (10), Beorlegui P (11), Gorgas MQ (12).

    (1) Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Calle Irunlarrea, 3, 31008, Pamplona, Navarra, Spain.
    (2) Instituto para el Uso Seguro de los Medicamentos (ISMP-España), Servicio de Farmacia Hospitalaria, Hospital Universitario de Salamanca, Salamanca, Spain.
    (3) Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Murcia, Spain.
    (4) Servicio de Farmacia Hospitalaria, Hospital Clínico San Carlos, Madrid, Spain.
    (5) Coordinadora de Enfermería Oncológica, Hospital Universitari Vall d'Hebron, Vall d'Hebron Instituto de Oncología, Barcelona, Spain.
    (6) Servicio de Oncología Médica, Hospital Universitario Doce de Octubre, Madrid, Spain.
    (7) Servicio de Farmacia Hospitalaria, Instituto Catalán de Oncología, Barcelona, Spain.
    (8) Adjunta de Enfermería, Hospital Virgen de los Lirios, Alcoy, Spain.
    (9) Universidad de Alicante, Alicante, Spain.
    (10) Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Seville, Spain.
    (11) Enfermería Clínica Avanzada, Clínica Universitaria de Navarra, Pamplona, Spain.
    (12) Servicio de Farmacia Hospitalaria, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

    Clinical Translational Oncology 01 APRIL 2019

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra